Q3 2025 Dishman Carbogen Amcis Ltd Earnings Call Transcript
Key Points
- Dishman Carbogen Amics Ltd (BOM:540701) reported a strong quarter with significant growth in operating profit and revenue.
- The company achieved a 230% increase in EBITDA compared to the previous year, indicating improved financial performance.
- Successful audit and expected certification of the French site, which is a major milestone for the company.
- The Swiss operations are performing well, with commercial production exceeding budget expectations.
- The company is focusing on strategic collaborations and synergies to drive future growth, particularly in the drug substance sector.
- The CEO, Pascal Villemagne, announced his resignation, which may lead to transitional challenges.
- The company faced a breach of financial covenants, leading to increased finance costs.
- The cholesterol and vitamin D analogs business in the Netherlands experienced difficulties due to competition and pricing pressures.
- Interest costs have increased significantly due to financial covenant breaches, impacting profit before tax.
- The French subsidiary is currently operating at a loss, although it is expected to break even next year.
Ladies and gentlemen, good day and welcome to the Diman Carboin Ays Limited Q3 F 525 earnings conference call. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Pascal Viameno.
Thank you and over to you, sir.
Thank you, moderator and good afternoon, Diahers.
Happy to, be with you, today.
And, it's a bit of a bittersweet moment that I have to address, to you today, as, you may have, read the in the recent news. I'm going to step down from my CEO at Caage GMC by the end of this fiscal year on the 31st of March.
It was an incredible journey and I'm extremely proud of what we have achieved together, from, the constant growth to the implementation of the new facility, of the product in France or the transformation of the Cabaz branch of the Diman Cabazian company.
The success are thanks to the amazing teams that have worked with me and to whom I'm deeply grateful. I thank also you,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
